Drug Information

Drug General Information
Drug ID
D0NE5P
Former ID
DIB018346
Drug Name
[3H]MRS1754
Synonyms
[3H]-MRS1754
Drug Type
Small molecular drug
Indication Discovery agent Investigative [467765]
Structure
Download
2D MOL
Formula
C26H26N6O4
InChI
InChI=1S/C26H26N6O4/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30)
InChIKey
AJBBEYXFRYFVNM-UHFFFAOYSA-N
PubChem Compound ID
6603931
PubChem Substance ID
11111478, 11646411, 14883713, 17405290, 24278793, 43223723, 48395000, 50106547, 50106548, 50106549, 52226893, 53777835, 56463251, 57370997, 85209186, 85231139, 85789113, 92304376, 103180854, 103985562, 114637051, 123051060, 124749949, 124799288, 124880758, 124880759, 127413921, 135650653, 135651182, 135698696, 162023183, 163122828, 170474554, 178127135, 181285846, 227454973, 241055655, 241376109, 249617683, 252156760, 252435845, 252451063
Target and Pathway
Target(s) Adenosine A2b receptor Target Info Antagonist [526013]
KEGG Pathway Rap1 signaling pathway
Calcium signaling pathway
Neuroactive ligand-receptor interaction
Vascular smooth muscle contraction
Alcoholism
NetPath Pathway TGF_beta_Receptor Signaling Pathway
TCR Signaling Pathway
Pathway Interaction Database C-MYB transcription factor network
PathWhiz Pathway Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
Reactome Adenosine P1 receptors
G alpha (s) signalling events
Surfactant metabolism
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 467765(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 453).
Ref 526013[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors. Biochem Pharmacol. 2001 Mar 15;61(6):657-63.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.